Peginterferon alpha-2B (peg-ifn)plus ribavirn (RBV) in Brazilian patients with chronic hepatitis C: 12 week viral clearence (2002)
- Authors:
- Autor USP: BARONE, ANTONIO ALCI - FM
- Unidade: FM
- Subjects: HEPATITE CRÔNICA; FARMACOTERAPIA; HEPATITE C
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Hepatology
- Volume/Número/Paginação/Ano: v. 36, n. 4, pt. 2 of 2, p. 588A, res. 1702
- Conference titles: Annual Meeting and Postgraduate Courses the American Association for the Study of Liver Diseases
-
ABNT
GONCALES JUNIOR, Fernando L.; VIGANI, Aline; GONCALES, Neiva; et al. Peginterferon alpha-2B (peg-ifn)plus ribavirn (RBV) in Brazilian patients with chronic hepatitis C: 12 week viral clearence. Hepatology[S.l: s.n.], 2002. -
APA
Goncales Junior, F. L., Vigani, A., Goncales, N., Coelho, H. S., Paixao, J., Rosa, H., et al. (2002). Peginterferon alpha-2B (peg-ifn)plus ribavirn (RBV) in Brazilian patients with chronic hepatitis C: 12 week viral clearence. Hepatology. Orlando. -
NLM
Goncales Junior FL, Vigani A, Goncales N, Coelho HS, Paixao J, Rosa H, Borges A, Barone AA, Araujo E, Focaccia R, Oliveira U, Ferraz ML, Perez R, Lobato C, Weirich J, Vila R, Giannella ML. Peginterferon alpha-2B (peg-ifn)plus ribavirn (RBV) in Brazilian patients with chronic hepatitis C: 12 week viral clearence. Hepatology. 2002 ; 36( 4): 588A. -
Vancouver
Goncales Junior FL, Vigani A, Goncales N, Coelho HS, Paixao J, Rosa H, Borges A, Barone AA, Araujo E, Focaccia R, Oliveira U, Ferraz ML, Perez R, Lobato C, Weirich J, Vila R, Giannella ML. Peginterferon alpha-2B (peg-ifn)plus ribavirn (RBV) in Brazilian patients with chronic hepatitis C: 12 week viral clearence. Hepatology. 2002 ; 36( 4): 588A. - Weigt-based combination therapy with peginterferon alfa 2b and ribavirin for naïve, relapser and non-responder patients with chronic hepatitis C
- Patients with chronic hepatitis C and normal transaminases
- Lesoes encefalicas cryptococcus neofarmans em um paciente com AIDS
- Effect of the technique of 'semen washing' in the removal of the hepatitis C virus in infected patients
- The importance of the HCV-NS4 peptide for the definition of serological types of hepatitis C virus
- Peginterferon A-2B plus ribavirin in relapser and mon-responder Brazilian HCV patients
- Imunopatogênese
- 72 weeks treatment duration reduces relapse rate in hcv/hiv co-infected patients with end of treatment response
- Pharmacodynamics of PEG-IFN-ALFA-2a and HCV response as a function of IL28B polymorphism in HIV/HCV-coinfected patients
- Clinical laboratory assessment of hepatitis C and HIV coinfected patients according to the anteretroviral therapy received
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas